screener
Wells Fargo +2.5%: the sell signal under management may soon flip
Wells Fargo stock rises 2.5% while the sell signal, in week 8 and in its management phase, has the short down 3.71%. Our model holds its previous stance, flags the risk of a reversal and suggests opening no new positions.
Western Digital +12.1%: the short still holds a 45.15% gain in week 20
Western Digital stock rises 12.1% while the sell signal, now in week 20, stays in its management phase. Our model shows the short still 45.15% in profit since entry, even after this week's sharp rally.
Verizon +1.5%: a new buy signal fires, but the stock stays on the watchlist
Verizon stock gains 1.5% on the week and triggers a new buy signal. The stock is on our watchlist: our model does not see it as tradable yet, so a new entry should wait, with the first scaling-out window in week 6.
VXUS +2.1%: the short on the sell signal is still 3.27% in profit
VXUS, Vanguard's international equity ETF, gains 2.1% with its sell signal now in week 7. In our technical analysis the trade is in its management phase, and the short opened on the signal is still 3.27% in profit.
VWO +2%: the sell signal on the emerging markets ETF moves into its management phase
VWO, the emerging markets ETF, gains 2% as its sell signal, now in week 5, enters the management phase. Our model shows the short still 2.84% in profit, and discipline suggests handling it with care after the weekly rally.
VTI +2.5%: the week 9 sell signal stays in its management phase
VTI, the total US stock market ETF, gains 2.5% on the week, with its sell signal now in week 9. In our model's technical analysis, the short now sits in its management phase and remains 1.15% in profit.
VT +2.4%: the sell signal enters its management phase, short still in profit
VT, the global equity ETF, gains 2.4% as its sell signal enters the management phase in week 5. In our technical analysis, the model shows the short still 0.97% in profit and suggests disciplined handling of the open position.
Vertex Pharmaceuticals -1.6%: buy signal holds in week 2 with standard size
Vertex Pharmaceuticals stock slips 1.6% on the week while the buy signal runs in week 2. Our model points to a standard position size, and the next scaling-out window comes in week 6, for 10% of the position.
Vertiv +10.5%: the short, now in week 25, still sits on a 36% gain
Vertiv stock gains 10.5%, while the sell signal, now in week 25, stays in its management phase with the short 36% in profit. Our model suggests carrying on with disciplined management of the trade, keeping the same approach even after this rebound.
Valero Energy +9.6%: the sell signal holds in week 3, short still ahead
Valero Energy stock rallies 9.6%, yet the sell signal, now in week 3, is still 4.96% in profit. Among US stocks on watch, our model advises against opening a fresh short: historically, short selling on the signal has lost money on average.
VIG +3.5%: 2 of 3 model references reached, full position size indicated
VIG, the Vanguard dividend growth ETF, gains 3.5% as its buy signal reaches week 4. In our technical analysis, the model points to a full position size and places the next scaling-out window, for 10% of the position, in week 6.
VGT +2.5%: short stays in profit as the sell signal enters its management phase
VGT, the technology sector ETF, gains 2.5% as its sell signal enters the management phase in week 5. In our technical analysis the short is still 6.44% in profit, and the model suggests managing the open position with discipline.
VGK +2.0%: a new buy signal, but the European equity ETF stays on watch
VGK, the European equity ETF, rises 2.0% and triggers a new buy signal. In our technical analysis the ETF is on watch: for our model it is not yet tradable, and a new entry should wait, with the first scaling-out window in week 6.
VFH +2.3%: buy signal in week 3, with our model pointing to a full position size
VFH, the Vanguard financials ETF, gains 2.3% on the week, with its buy signal now in week 3. In our technical analysis, the model points to a full position size and places the next scaling-out window in week 6, for 10% of the position.